What has the immune system got against the glomerular podocyte?

Clinical and Experimental Immunology

Volumn 134, Issue 1, 2003, Pages 1-5

  Mathieson, Peter W ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; COMPLEMENT COMPONENT C1; COMPLEMENT MEMBRANE ATTACK COMPLEX; CORTICOSTEROID; CYTOKINE RECEPTOR; DEXAMETHASONE; FIBROBLAST GROWTH FACTOR 2; I KAPPA B; INTERLEUKIN 1; TRANSFORMING GROWTH FACTOR BETA;

CELL REGENERATION; COMPLEMENT SYSTEM; CONGENITAL NEPHROTIC SYNDROME; CYTOKINE PRODUCTION; GLOMERULOPATHY; GLOMERULOSCLEROSIS; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION; HEYMANN NEPHRITIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; KIDNEY DISEASE; KIDNEY FAILURE; MEMBRANOUS GLOMERULONEPHRITIS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; REVIEW;

COMPLEMENT SYSTEM PROTEINS; EPITHELIAL CELLS; GLOMERULONEPHRITIS; GLUCOCORTICOIDS; HUMANS; IMMUNE SYSTEM; IMMUNE SYSTEM DISEASES; KIDNEY GLOMERULUS; MICROSCOPY, ELECTRON, SCANNING; RECEPTORS, CHEMOKINE; RECEPTORS, CYTOKINE;

EID: 0141539470     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02236.x     Document Type: Review

References (32)

1. Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003; 83:253-307.
2. Bernard D. Extra-renal complications of the nephrotic syndrome. Kidney Int 1988; 33:1184-202.
3. Mathieson PW. Role of the podocyte in glomerular injury. Hong Kong J Nephrol 2001; 3:51-6.
4. Trompeter RS, Barratt TM. Treatment and management of the nephrotic syndrome in children. In: Cameron JS, Glassock RJ, Whelton A, eds. The nephrotic syndrome. New York: Marcel Dekker, Inc., 1988:423-60.
5. Shalhoub RJ. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 1974; ii:556-60.
6. Mathieson PW. Immune dysregulation in minimal change nephropathy. Nephrol Dial Transplant 2003; 18 (Suppl. 6):1-4.
7. Parry RG, Gillespie KM, Mathieson PW. Effects of type 2 cytokines on cultured human glomerular epithelial cells. Exp Nephrol 2001; 9:275-83.
8. Van den Berg JG, Aten J, Chand MA et al. Interleukin-4 and interleukin-13 act on glomerular visceral epithelial cells. J Am Soc Nephrol 2000; 11:413-22.
9. + and cathepsin L by glomerular visceral epithelial cells. Am J Physiol Renal Physiol 2002; 282:F26-F33.
10. Coers W, Vos JT, van der Meide PH, van der Horst ML, Huitema S, Weening JJ. Interferon-gamma (IFN-γ) and IL-4 expressed during mercury-induced membranous nephropathy are toxic for cultured podocytes. Clin Exp Immunol 1995; 102:297-307.
11. Huber TB, Reinhardt HC, Exner M et al. Expression of functional CCR and CXCR chemokine receptors in podocytes. J Immunol 2002; 168:6244-52.
12. Sharma M, Sharma R, Reddy SR, McCarthy ET, Savin VJ. Proteinuria after injection of human focal segmental glomerulosclerosis factor. Transplantation 2002; 73:366-72.
13. Schwartz MM. The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis. Ren Fail 2000; 22:663-84.
14. Bariety J, Bruneval P, Hill G, Irinopoulou T, Mandet C, Meyrier A. Posttransplantation relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation. J Am Soc Nephrol 2001; 12:261-74.
15. Kerjaschki D, Neale TJ. Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis). J Am Soc Nephrol 1996; 7:2518-26.
16. Mudge SJ, Paizis K, Auwardt RB, Thomas RJ, Power DA. Activation of nuclear factor-kappa B by podocytes in the autologous phase of passive Heymann nephritis. Kidney Int 2001; 59:923-31.
17. Barisoni L, Kriz W, Mundel P, D'Agati V. The dysregulated podocyte phenotype, a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 1999; 10:51-61.
18. Barisoni L, Bruggeman LA, Mundel P, D'Agati VD, Klotman PE. HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney Int 2000; 58:173-81.
19. Schwartz EJ, Cara A, Snoeck H et al. Human immunodeficiency virus-1 induces loss of contact inhibition in podocytes. J Am Soc Nephrol 2001; 12:1677-84.
20. Hishiki T, Shirato I, Takahashi Y, Funabiki K, Horikoshi S, Tomino Y. Podocyte injury predicts prognosis in patients with iga nephropathy using a small amount of renal biopsy tissue. Kidney Blood Press Res 2001; 24:99-104.
21. Meyer TW, Bennett PH, Nelson RG. Podocyte number predicts long-term urinary albumin excretion in Pima Indians with type II diabetes and microalbuminuria. Diabetologia 1999; 42:1341-4.
22. Kriz W, Gretz N, Lemley K. Progression of glomerular diseases: is the podocyte the culprit? Kidney Int 1998; 54:687-97.
23. Niemir ZI, Stein H, Dworacki G et al. Podocytes are the major source of IL-1 alpha and IL-1 beta in human glomerulonephritides. Kidney Int 1997; 52:393-403.
24. Sacks SH, Zhou W, Pani A, Campbell RD, Martin J. Complement C3 gene expression and regulation in human glomerular epithelial cells. Immunology 1993; 79:348-54.
25. Kazatchkine MD, Fearon DT, Appay MD, Mandet C, Bariety J. Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases. J Clin Invest 1982; 69:900-12.
26. Teixeira JE, Costa RS, Lachmann PJ, Wurzner R, Barbosa JE. CR1 stump peptide and terminal complement complexes are found in the glomeruli of lupus nephritis patients. Clin Exp Immunol 1996; 105:497-503.
27. Pippin JW, Durvasula R, Petermann A, Hiromura K, Couser WG, Shankland SJ. DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes. J Clin Invest 2003; 111:877-85.
28. Saleem MA, O'Hare MJ, Reiser J et al. A conditionally immortalised human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 2002; 13:630-8.
29. Xing CY, Saleem MA, Ni L, Mathieson PW. Effects of dexamethasone on the expression and distribution of glucocorticoid receptor in human cultured podocytes. J Am Soc Nephrol 2000; 11:430A.
30. Xing CY, Saleem MA, Ni L, Mathieson PW. Dexamethasone increases the proliferation and differentiation of human cultured podocytes. J Am Soc Nephrol 2000; 11:468A.
31. Eremina V, Sood M, Haigh J et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003; 111:707-16.
32. Bugeon L, Danou A, Carpentier D, Langridge P, Syed N, Dallman MJ. Inducible gene silencing in podocytes: a new tool for studying glomerular function. J Am Soc Nephrol 2003; 14:786-91.